DREAMM-7 Phase III Trial: Blenrep Combination Increases Median Progression-Free Survival for Relapsed/Refractory Multiple Myeloma Patients (https://www.myeloma.org/news-events/multiple-myeloma-news/DREAM-7-phase-3-trial-blenrep-combination-increases-median-pfs)